These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 15019641

  • 21. Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients.
    Samman A, Imai C, Straatman L, Frolich J, Humphries K, Ignaszewski A.
    J Heart Lung Transplant; 2005 Aug; 24(8):1008-13. PubMed ID: 16102434
    [Abstract] [Full Text] [Related]

  • 22. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C, de la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez-Sanz R, Gómez-Izquierdo T, Larumbe S, Moreno E, Rodicio JL, del Palacio A.
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [Abstract] [Full Text] [Related]

  • 23. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
    Kobashigawa JA, Moriguchi JD, Laks H, Wener L, Hage A, Hamilton MA, Cogert G, Marquez A, Vassilakis ME, Patel J, Yeatman L.
    J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
    [Abstract] [Full Text] [Related]

  • 24. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
    Law YM, Yim R, Agatisa P, Boyle GJ, Miller SA, Lawrence K, Webber SA.
    J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
    [Abstract] [Full Text] [Related]

  • 25. Hyperlipidemia after clinical heart transplantation.
    Taylor DO, Thompson JA, Hastillo A, Barnhart G, Rider S, Lower RR, Hess ML.
    J Heart Transplant; 1989 Mar; 8(3):209-13; discussion 219-20. PubMed ID: 2661770
    [Abstract] [Full Text] [Related]

  • 26. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
    Crespo-Leiro MG, Paniagua MJ, Marzoa R, Grille Z, Naya C, Flores X, Rodriguez JA, Mosquera V, Franco R, Castro-Beiras A.
    Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M, Koizumi J, Miyamoto S, Origasa H, Mabuchi H, HOLICOS-PAT Study Group.
    Int J Cardiol; 2005 Mar 30; 99(3):395-401. PubMed ID: 15771919
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 30; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 32. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.
    Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D.
    Curr Med Res Opin; 2005 Sep 30; 21(9):1389-99. PubMed ID: 16197657
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
    Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A, Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group.
    Am Heart J; 2004 Apr 30; 147(4):705-13. PubMed ID: 15077101
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia.
    Hedman M, Neuvonen PJ, Neuvonen M, Antikainen M.
    Clin Pharmacol Ther; 2003 Aug 30; 74(2):178-85. PubMed ID: 12891228
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ezetimibe treatment of pediatric patients with hypercholesterolemia.
    Clauss S, Wai KM, Kavey RE, Kuehl K.
    J Pediatr; 2009 Jun 30; 154(6):869-72. PubMed ID: 19230898
    [Abstract] [Full Text] [Related]

  • 39. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 30; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.